CN106176778A - 异类叶升麻苷或其药学上可接受的盐的用途 - Google Patents

异类叶升麻苷或其药学上可接受的盐的用途 Download PDF

Info

Publication number
CN106176778A
CN106176778A CN201610646844.2A CN201610646844A CN106176778A CN 106176778 A CN106176778 A CN 106176778A CN 201610646844 A CN201610646844 A CN 201610646844A CN 106176778 A CN106176778 A CN 106176778A
Authority
CN
China
Prior art keywords
disease
isoacteoside
purposes
amyloid beta
situation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610646844.2A
Other languages
English (en)
Chinese (zh)
Inventor
林汉钦
苏慕寰
黄永名
唐静静
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sinphar Tian Li Pharmaceutical Co Ltd
Original Assignee
Sinphar Tian Li Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinphar Tian Li Pharmaceutical Co Ltd filed Critical Sinphar Tian Li Pharmaceutical Co Ltd
Publication of CN106176778A publication Critical patent/CN106176778A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/64—Orobanchaceae (Broom-rape family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN201610646844.2A 2010-06-16 2011-06-16 异类叶升麻苷或其药学上可接受的盐的用途 Pending CN106176778A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35516910P 2010-06-16 2010-06-16
US61/355169 2010-06-16
CN2011800298829A CN103037868A (zh) 2010-06-16 2011-06-16 异类叶升麻苷或其药学上可接受的盐的用途

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2011800298829A Division CN103037868A (zh) 2010-06-16 2011-06-16 异类叶升麻苷或其药学上可接受的盐的用途

Publications (1)

Publication Number Publication Date
CN106176778A true CN106176778A (zh) 2016-12-07

Family

ID=44303534

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201610646844.2A Pending CN106176778A (zh) 2010-06-16 2011-06-16 异类叶升麻苷或其药学上可接受的盐的用途
CN2011800298829A Pending CN103037868A (zh) 2010-06-16 2011-06-16 异类叶升麻苷或其药学上可接受的盐的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2011800298829A Pending CN103037868A (zh) 2010-06-16 2011-06-16 异类叶升麻苷或其药学上可接受的盐的用途

Country Status (11)

Country Link
US (1) US20120009131A1 (enExample)
EP (1) EP2397144B1 (enExample)
JP (1) JP5968878B2 (enExample)
KR (1) KR101847501B1 (enExample)
CN (2) CN106176778A (enExample)
AU (1) AU2011267724B2 (enExample)
CA (1) CA2802441C (enExample)
MY (1) MY160878A (enExample)
SG (1) SG186717A1 (enExample)
TW (1) TWI486162B (enExample)
WO (1) WO2011157059A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108785320A (zh) * 2018-04-13 2018-11-13 浙江大学 异毛蕊花糖苷在制备激活Nrf2-ARE信号通路的保健品/药品中的应用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2044951A1 (en) * 2007-10-02 2009-04-08 Merz Pharma GmbH & Co. KGaA The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
MY171048A (en) * 2011-12-16 2019-09-23 Sinphar Tian Li Pharmaceutical Co Ltd Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions
CN103622980A (zh) * 2013-12-12 2014-03-12 宁夏医科大学 肉苁蓉苯乙醇苷类化合物作为制备治疗骨质疏松症药物的应用及药物组合物
US20150291645A1 (en) * 2014-04-10 2015-10-15 Sinphar Pharmaceutical Co., Ltd. Isoacteoside derivative and use thereof
TWI650131B (zh) * 2014-07-03 2019-02-11 杏輝藥品工業股份有限公司 管花肉蓯蓉萃取物之用於製備保護眼部細胞之藥品或食品用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040064830A (ko) * 2003-01-10 2004-07-21 주식회사 엘컴사이언스 페닐에타노이드 유도체를 포함하는 퇴행성 뇌신경계질환의 예방 및 치료용 조성물
EP1736167A2 (en) * 2005-06-20 2006-12-27 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Extracts obtained from cell line cultures from plants belonging to the Oleaceae family (e.g. Syringa vulgaris), their preparation and use
WO2007125351A1 (en) * 2006-04-27 2007-11-08 Senexis Limited Pyrimidine derivatives for the treatment of amyloid-related diseases
CN101264094A (zh) * 2008-04-16 2008-09-17 西藏自治区高原生物研究所 藏波罗花苯丙素苷组合物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100500584B1 (ko) * 2002-08-12 2005-07-12 경희대학교 산학협력단 신경성장인자와 유사 작용을 갖는 육종용 추출물 및 이를함유하는 조성물
TW200416036A (en) * 2003-02-18 2004-09-01 Sinphar Pharmaceutical Co Ltd Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same
CN1268341C (zh) * 2003-03-04 2006-08-09 杏辉天力（杭州）药业有限公司 来源于管花肉苁蓉的含有苯乙醇苷的制剂及其制备方法和用途
JP2006312594A (ja) * 2005-05-06 2006-11-16 Univ Nihon 学習・記憶障害予防用組成物
JP4936507B2 (ja) * 2006-01-18 2012-05-23 学校法人近畿大学 カンカニクジュヨウの抽出物より得られる強壮剤又は強精剤、配糖体化合物及びそれらの用途
CN100446792C (zh) * 2006-03-21 2008-12-31 中国海洋大学 一种改善记忆的中药
JP5410683B2 (ja) * 2008-02-19 2014-02-05 学校法人近畿大学 カンカニクジュヨウから得られる肝保護剤及び抗ＴＮＦ−α作用剤
JP2009196908A (ja) * 2008-02-20 2009-09-03 Yomeishu Seizo Co Ltd リパーゼ阻害剤及び飲食品
JP2009209063A (ja) * 2008-03-03 2009-09-17 Univ Kinki 皮膚外用剤または皮膚化粧料
JP2009263279A (ja) * 2008-04-25 2009-11-12 Oriza Yuka Kk エラスターゼ阻害剤
CN101703125B (zh) * 2009-12-04 2012-07-04 中国科学院新疆生态与地理研究所 肉苁蓉红茶及其制备方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040064830A (ko) * 2003-01-10 2004-07-21 주식회사 엘컴사이언스 페닐에타노이드 유도체를 포함하는 퇴행성 뇌신경계질환의 예방 및 치료용 조성물
EP1736167A2 (en) * 2005-06-20 2006-12-27 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Extracts obtained from cell line cultures from plants belonging to the Oleaceae family (e.g. Syringa vulgaris), their preparation and use
WO2007125351A1 (en) * 2006-04-27 2007-11-08 Senexis Limited Pyrimidine derivatives for the treatment of amyloid-related diseases
CN101264094A (zh) * 2008-04-16 2008-09-17 西藏自治区高原生物研究所 藏波罗花苯丙素苷组合物及其制备方法和用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王建刚: "《临床药理学》", 31 December 2008 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108785320A (zh) * 2018-04-13 2018-11-13 浙江大学 异毛蕊花糖苷在制备激活Nrf2-ARE信号通路的保健品/药品中的应用

Also Published As

Publication number Publication date
TW201200137A (en) 2012-01-01
KR101847501B1 (ko) 2018-05-24
AU2011267724B2 (en) 2016-07-28
JP5968878B2 (ja) 2016-08-10
CN103037868A (zh) 2013-04-10
TWI486162B (zh) 2015-06-01
EP2397144B1 (en) 2014-12-31
CA2802441A1 (en) 2011-12-22
WO2011157059A1 (zh) 2011-12-22
AU2011267724A1 (en) 2013-01-24
CA2802441C (en) 2018-08-07
EP2397144A1 (en) 2011-12-21
JP2013528627A (ja) 2013-07-11
MY160878A (en) 2017-03-31
US20120009131A1 (en) 2012-01-12
KR20130095246A (ko) 2013-08-27
SG186717A1 (en) 2013-02-28

Similar Documents

Publication Publication Date Title
CN106176778A (zh) 异类叶升麻苷或其药学上可接受的盐的用途
CN109640983A (zh) 醛捕获化合物和其用途
MX2014016044A (es) Mejoramiento de autofagia o incremento de longevidad por administracion de urolitinas o precursores de las mismas.
KR20110124704A (ko) 단핵식세포계 세포 내에서 ａｇｅ-알부민의 합성 저해 또는 분비 저해에 의한 세포사 유도 저해 방법
JP7248840B2 (ja) くすぶり炎症抑制剤
CA2642524A1 (en) External preparation for skin containing flavanone derivative
CN106361738A (zh) 治疗、预防脑白质损伤的医药组合物及其医药用途
Xing et al. The protective effects of ecdysterone on cognitive impairment through regulating akt/GSK-3β/nrf2 signaling pathway and oxidative stress in cognitive mice model and aβ-induced cell neurotoxicity
KR20040073425A (ko) 두뇌 또는 인지 기능 증진용 조성물
CN109069450A (zh) 神经障碍的新的组合疗法
Zhang et al. Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices
CN106265713A (zh) 虫草素在制备抗抑郁症的药物中的用途及其制备而得的快速抗抑郁症药物
JP2001139483A (ja) 薬用人蔘からなる脳細胞または神経細胞保護剤
CN112043700B (zh) 盐酸去亚甲基四氢小檗碱在制备预防或治疗神经退行性疾病药物中的应用
CN117122685A (zh) Rage抑制剂在制备预防或治疗听力损伤的产品中的用途
US20180036257A1 (en) Zeaxanthin for tumor treatment
JP2024525766A (ja) アミロイドベータオリゴマー化の阻害剤及びその治療用途
CN102028681B (zh) 椒苯酮胺或其盐在制备预防/治疗脑病的药物中的用途
Yan et al. Deoxyschizandrin attenuates Aβ1–42-induced cognitive impairments through up-regulation of AMPA receptors in mice
US20130072474A1 (en) Treatment of dementia of alzheimer's type with masitinib
Hardeman III The Importance of Timing in Repeated Traumatic Brain Injury
WO2025053283A1 (ja) ベルベルビン関連化合物
KR20130091604A (ko) 시난디온 ａ를 포함하는 항염증용 조성물
CN111225667A (zh) 一种1,2,3,6,7-五甲氧基二苯吡酮在制备防治海马神经元相关疾病药物的应用
Van der Zeyden The Effect of Hydrocortisone and Methylphenidate on the Growth of Murine L929 Fibroblast and Chick Brain Neuronal Cells

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20161207

RJ01 Rejection of invention patent application after publication